tiprankstipranks
Trending News
More News >
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX
US Market
Advertisement

Royalty Pharma (RPRX) Ratios

Compare
1,270 Followers

Royalty Pharma Ratios

RPRX's free cash flow for Q2 2025 was $0.00. For the 2025 fiscal year, RPRX's free cash flow was decreased by $ and operating cash flow was $0.28. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.26 7.90 2.19 16.81 8.76
Quick Ratio
1.26 7.90 2.19 16.81 6.63
Cash Ratio
0.52 2.96 1.47 9.00 3.28
Solvency Ratio
0.12 0.24 <0.01 0.07 0.08
Operating Cash Flow Ratio
2.05 18.51 1.84 11.78 6.61
Short-Term Operating Cash Flow Coverage
2.47 0.00 2.15 0.00 0.00
Net Current Asset Value
$ -7.30B$ -5.02B$ -4.73B$ -4.39B$ -3.43B
Leverage Ratios
Debt-to-Assets Ratio
0.44 0.37 0.42 0.41 0.28
Debt-to-Equity Ratio
1.26 0.94 1.26 1.23 0.59
Debt-to-Capital Ratio
0.56 0.48 0.56 0.55 0.37
Long-Term Debt-to-Capital Ratio
0.52 0.48 0.52 0.55 0.37
Financial Leverage Ratio
2.89 2.51 2.99 3.03 2.13
Debt Service Coverage Ratio
1.35 10.08 0.63 4.16 3.42
Interest Coverage Ratio
6.92 7.97 5.20 8.61 10.16
Debt to Market Cap
0.52 0.49 0.41 0.43 0.31
Interest Debt Per Share
19.57 14.13 16.68 17.51 15.91
Net Debt to EBITDA
3.90 3.00 5.82 3.82 2.86
Profitability Margins
Gross Profit Margin
74.83%76.19%99.75%99.00%95.85%
EBIT Margin
83.75%80.15%18.69%62.49%87.61%
EBITDA Margin
82.10%80.15%41.51%63.50%79.34%
Operating Profit Margin
79.85%63.37%43.69%62.49%75.16%
Pretax Profit Margin
72.19%72.20%10.28%54.21%80.21%
Net Profit Margin
44.26%48.20%1.91%20.91%23.34%
Continuous Operations Profit Margin
66.73%72.20%10.28%54.21%80.21%
Net Income Per EBT
61.31%66.75%18.62%38.57%29.10%
EBT Per EBIT
90.41%113.94%23.54%86.75%106.71%
Return on Assets (ROA)
5.57%6.93%0.25%2.73%2.35%
Return on Equity (ROE)
15.20%17.39%0.76%8.29%5.00%
Return on Capital Employed (ROCE)
10.76%9.20%6.25%8.25%7.67%
Return on Invested Capital (ROIC)
9.02%9.20%1.09%3.18%3.31%
Return on Tangible Assets
45.07%6.93%0.25%2.73%2.35%
Earnings Yield
6.61%9.03%0.25%2.90%2.64%
Efficiency Ratios
Receivables Turnover
2.65 3.04 3.07 3.35 3.39
Payables Turnover
0.08 36.97 0.72 4.09 8.18
Inventory Turnover
0.00 0.00 5.67M 23.00M 0.13
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.13 0.14 0.13 0.13 0.10
Working Capital Turnover Ratio
4.73 1.88 1.09 0.90 1.47
Cash Conversion Cycle
-4.32K 110.28 -390.18 19.63 2.79K
Days of Sales Outstanding
137.84 120.15 118.76 108.83 107.74
Days of Inventory Outstanding
0.00 0.00 <0.01 <0.01 2.72K
Days of Payables Outstanding
4.46K 9.87 508.94 89.20 44.64
Operating Cycle
137.84 120.15 118.76 108.83 2.83K
Cash Flow Ratios
Operating Cash Flow Per Share
5.83 6.68 4.90 4.86 5.42
Free Cash Flow Per Share
5.83 6.68 9.56 4.87 11.27
CapEx Per Share
0.00 0.00 4.66 <0.01 5.85
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.95 1.00 2.08
Dividend Paid and CapEx Coverage Ratio
6.56 8.34 0.90 7.06 0.78
Capital Expenditure Coverage Ratio
0.00 0.00 1.05 3.86K 0.93
Operating Cash Flow Coverage Ratio
0.31 0.49 0.30 0.28 0.35
Operating Cash Flow to Sales Ratio
1.07 1.27 0.96 0.88 0.96
Free Cash Flow Yield
16.07%23.76%24.18%12.21%22.52%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
15.13 11.08 404.10 34.53 37.95
Price-to-Sales (P/S) Ratio
6.66 5.34 7.74 7.22 8.86
Price-to-Book (P/B) Ratio
2.43 1.93 3.08 2.86 1.90
Price-to-Free Cash Flow (P/FCF) Ratio
6.22 4.21 4.14 8.19 4.44
Price-to-Operating Cash Flow Ratio
6.25 4.21 8.07 8.19 9.24
Price-to-Earnings Growth (PEG) Ratio
-2.70 <0.01 -4.42 -2.68 -0.48
Price-to-Fair Value
2.43 1.93 3.08 2.86 1.90
Enterprise Value Multiple
12.02 9.66 24.46 15.19 14.02
Enterprise Value
22.75B 18.23B 22.71B 22.08B 23.60B
EV to EBITDA
12.02 9.66 24.46 15.19 14.02
EV to Sales
9.87 7.74 10.15 9.65 11.12
EV to Free Cash Flow
9.21 6.10 5.43 10.94 5.58
EV to Operating Cash Flow
9.21 6.10 10.59 10.95 11.60
Tangible Book Value Per Share
-15.48 22.53 21.72 24.69 39.80
Shareholders’ Equity Per Share
14.99 14.58 12.85 13.93 26.36
Tax and Other Ratios
Effective Tax Rate
0.11 0.00 0.81 0.61 0.67
Revenue Per Share
5.44 5.26 5.11 5.52 5.65
Net Income Per Share
2.41 2.54 0.10 1.15 1.32
Tax Burden
0.61 0.67 0.19 0.39 0.29
Interest Burden
0.86 0.90 0.55 0.87 0.92
Research & Development to Revenue
0.15 0.02 0.08 0.09 0.01
SG&A to Revenue
0.18 0.11 0.10 0.08 0.09
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.54 1.76 9.32 1.63 1.20
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis